01053nas a2200337   4500000000100000000000100001008004100002653001400043653005900057653003000116653007400146653006300220100001300283700001500296700001300311700001200324700001500336700001600351700001200367700001200379700001500391700001500406700001300421700001300434700001500447245020500462250001500667300001200682490000700694020001400701       2023                            d10aadherence10achronic obstructive pulmonary disease (COPD) treatment10acomparative effectiveness10ainhaled corticosteroid/long-actingβ2-agonist (ICS/LABA) dual therapy10along-acting muscarinic antagonist (LAMA)/LABA dual therapy1 aA. Czira1 aG. Requena1 aV. Banks1 aR. Wood1 aT. Tritton1 aC. Castillo1 aJ. Yeap1 aR. Wild1 aC. Compton1 aK. Rothnie1 aF. Herth1 aJ. Quint1 aA. Ismaila00aComparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England  a2023/05/08  a643-6590 v18  a1176-9106